or Try an Advanced Search...

    Technical Analysis for ITRM - Iterum Therapeutics plc

    Grade Last Price % Change Price Change
    C 1.22 -5.43% -0.07
    ITRM closed down 5.43 percent on Friday, November 1, 2024, on 77 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical ITRM trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Calm After Storm Range Contraction -5.43%
    NR7 Range Contraction -5.43%
    Narrow Range Bar Range Contraction -5.43%
    Inside Day Range Contraction -5.43%
    Wide Bands Range Expansion -5.43%
    Gapped Up Strength -5.43%
    Fell Below 200 DMA Bearish 0.83%
    Wide Bands Range Expansion 0.83%
    Older End-of-Day Signals for ITRM ...

       Recent Intraday Alerts

    Alert Time
    Down 10% 1 day ago
    10 DMA Resistance 1 day ago
    Down 5% 1 day ago
    Down 3% 1 day ago
    Fell Below Previous Day's Low 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ITRM Chart by TradingView
    Basic chart:

    Profile

    Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Stage Pharmaceutical

    Is ITRM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 Iterum Therapeutics plc (ITRM) U.S. FDA Approval of ORLYNVAH Call (Transcript)
    Oct 28 FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
    Oct 28 FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
    Oct 28 Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
    Oct 25 Iterum stock rallies 54% on FDA approval of Orlynvah for UTIs
    Oct 25 Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
    Oct 10 Iterum Therapeutics to Present Data at IDWeek 2024
    Oct 9 Iterum Therapeutics to Participate at the 2024 Maxim Healthcare Virtual Summit
    Sep 24 Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship efforts
    Sep 10 Iterum stock falls 9% in wake of FDA AdComm meeting on UTI drug
    See more ITRM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.5
    52 Week Low 0.705
    Average Volume 2,842,410
    200-Day Moving Average 1.35
    50-Day Moving Average 1.11
    20-Day Moving Average 1.15
    10-Day Moving Average 1.30
    Average True Range 0.19
    RSI (14) 51.22
    ADX 35.09
    +DI 36.61
    -DI 16.57
    Chandelier Exit (Long, 3 ATRs) 1.75
    Chandelier Exit (Short, 3 ATRs) 1.38
    Upper Bollinger Bands 1.60
    Lower Bollinger Band 0.70
    Percent B (%b) 0.58
    BandWidth 78.27
    MACD Line 0.07
    MACD Signal Line 0.06
    MACD Histogram 0.0138
    Fundamentals Value
    Market Cap 16.39 Million
    Num Shares 13.4 Million
    EPS -2.43
    Price-to-Earnings (P/E) Ratio -0.50
    Price-to-Sales 1349.79
    Price-to-Book 6.30
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.46
    Resistance 3 (R3) 1.47 1.39 1.42
    Resistance 2 (R2) 1.39 1.33 1.39 1.41
    Resistance 1 (R1) 1.31 1.29 1.27 1.30 1.39
    Pivot Point 1.23 1.23 1.22 1.23 1.23
    Support 1 (S1) 1.15 1.17 1.11 1.14 1.05
    Support 2 (S2) 1.07 1.13 1.07 1.03
    Support 3 (S3) 0.99 1.07 1.02
    Support 4 (S4) 0.98